BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17111879)

  • 1. [Pancreatic cancer].
    Schmid RM
    Praxis (Bern 1994); 2006 Nov; 95(44):1709-12. PubMed ID: 17111879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
    Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Will molecular diagnostics become established in pancreatic pathology?].
    Sipos B; Sperveslage J
    Pathologe; 2013 Nov; 34 Suppl 2():214-20. PubMed ID: 24196616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Effect of Driver Mutations of
    Gu Y; Ji Y; Jiang H; Qiu G
    Genet Test Mol Biomarkers; 2020 Dec; 24(12):777-788. PubMed ID: 33347393
    [No Abstract]   [Full Text] [Related]  

  • 5. The Roles of Frequently Mutated Genes of Pancreatic Cancer in Regulation of Tumor Microenvironment.
    Sun H; Zhang B; Li H
    Technol Cancer Res Treat; 2020; 19():1533033820920969. PubMed ID: 32372692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New perspectives for radiosensitization in pancreatic carcinoma: a review of mechanisms involved in pancreatic tumorigenesis].
    Huguet F; Fernet M; Monnier L; Touboul E; Favaudon V
    Cancer Radiother; 2011 Aug; 15(5):365-75. PubMed ID: 21664851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer.
    Kamisawa T; Wood LD; Itoi T; Takaori K
    Lancet; 2016 Jul; 388(10039):73-85. PubMed ID: 26830752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
    Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
    Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia: report of a case.
    Krishnasamy R; Agarwal S; Singh S; Puri S; Sakhuja P; Agarwal AK
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):553-6. PubMed ID: 17897923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma.
    McIntyre CA; Lawrence SA; Richards AL; Chou JF; Wong W; Capanu M; Berger MF; Donoghue MTA; Yu KH; Varghese AM; Kelsen DP; Park W; Balachandran VP; Kingham TP; D'Angelica MI; Drebin JA; Jarnagin WR; Iacobuzio-Donahue CA; Allen PJ; O'Reilly EM
    Cancer; 2020 Sep; 126(17):3939-3949. PubMed ID: 32573775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differentiated therapy for intraductal papillary mucinous neoplasms].
    Wente MN; Schmied BM; Schmidt J; Büchler MW
    Chirurg; 2009 Jan; 80(1):7-13. PubMed ID: 19082569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma.
    Kawesha A; Ghaneh P; Andrén-Sandberg A; Ograed D; Skar R; Dawiskiba S; Evans JD; Campbell F; Lemoine N; Neoptolemos JP
    Int J Cancer; 2000 Nov; 89(6):469-74. PubMed ID: 11102889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma.
    Andea A; Sarkar F; Adsay VN
    Mod Pathol; 2003 Oct; 16(10):996-1006. PubMed ID: 14559982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.
    Biankin AV; Biankin SA; Kench JG; Morey AL; Lee CS; Head DR; Eckstein RP; Hugh TB; Henshall SM; Sutherland RL
    Gut; 2002 Jun; 50(6):861-8. PubMed ID: 12010891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Where and when does pancreatic carcinoma start?
    Lüttges J; Hahn S; Klöppel G
    Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Strategies for screening for pancreatic adenocarcinoma in high-risk patients: the place of endoscopic ultrasound].
    Béchade D
    Presse Med; 2011 Mar; 40(3):230-8. PubMed ID: 21211938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16, p21, and p53 proteins play an important role in development of pancreatic intraepithelial neoplastic.
    Zińczuk J; Zaręba K; Guzińska-Ustymowicz K; Kędra B; Kemona A; Pryczynicz A
    Ir J Med Sci; 2018 Aug; 187(3):629-637. PubMed ID: 29388054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics and Biology of Pancreatic Ductal Adenocarcinoma.
    Dunne RF; Hezel AF
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):595-608. PubMed ID: 26226899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.
    Bardeesy N; Cheng KH; Berger JH; Chu GC; Pahler J; Olson P; Hezel AF; Horner J; Lauwers GY; Hanahan D; DePinho RA
    Genes Dev; 2006 Nov; 20(22):3130-46. PubMed ID: 17114584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma.
    Zhang L; Sanderson SO; Lloyd RV; Smyrk TC
    Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.